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NOS OXYGENASE-MEDIATED NITROALKANE CATALYTIC
REDUCTION: IMPACT ON NOS REACTION

PRANEETH IVAN JOEL FNU

`

ABSTRACT

Organic nitroalkanes are used in many industries and for a variety of purposes. Their
use is expanding and is steadily claiming new territories in our immediate environment.
Some nitroalkanes, when they enter the human body, can be harmful as such or can be
activated to generate reactive intermediates with known detrimental effects. P450
enzymes are known for metabolizing a variety of drugs and substances including organic
nitroalkanes. Nitric oxide synthases (NOS) exhibit some similarities to P450
metalloenzymes and their potential interaction with nitroalkanes as xenobiotics is not
well known. The present study investigates the effect of nitroalkanes on the catalytic
reaction of NOS in light of the NOS-mediated catalytic reduction of the same
nitroalkanes.
In this work, we used the recombinant oxygenase domain of inducible nitric oxide
synthase (iNOSoxy) and endothelial nitric oxide synthase (eNOSoxy). We have
previously shown that the oxygenase domain of nitric oxide synthases (NOSs) in thin
surfactant films can exchange electrons with the underlying electrode. We show in the
current work that NOS oxygenase domains act as efficient electrocatalysts for
nitroalkane reductions in surfactant films on pyrolytic graphite electrodes. We
monitored the NOSoxy-mediated catalytic reduction of a series of nitroalkanes using
electrochemical techniques. Concomitantly, we used chemical assays such as the Griess
assay to assess enzymatic activity of NOSoxys under the same conditions.
Voltammograms at different concentrations of nitroalkanes and different scan rates were
used to derive catalytic parameters such as catalytic efficiency, Km and kcat values for
iii

NOSoxy-mediated catalytic reduction of nitroalkanes. Overall, we present a comparative
study of the electroreduction of nitromethane, nitroethane, and nitropropane using
eNOSoxy and iNOSoxy as electrocatalysts. We also compare and contrast how -and the
extent to which- each nitroalkane affects the catalytic NOS reaction by iNOSoxy and
eNOSoxy.
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GENERAL INTRODUCTION
Organic Nitroalkanes (Nitromethane, Nitroethane and Nitropropane) are
constantly released into the environment as they are used by a variety of industries. For
example, they are used by drag racers and hobbyists as fuel in race cars, in the
manufacture of explosives like TNT[1], in the pharmaceutical industry, and in the
manufacture of pesticides and fungicides [2]. Nitroalkanes are considered to be harmful
to the human body. Enough evidence about the health hazards of exposure to
nitroalkanes accumulated from workers directly exposed and from the general
population[2].
Nitroalkanes released through spills from industries, during their transportation
or from the emissions of cars and rockets, can enter the body by inhalation, skin contact
or through food, causing serious side effects to the human body[3]. These side effects
range from normal problems like nausea and headaches, to serious problems like
convulsions and even death when inhaled in a chronic manner. At the cellular level, they
can cause problems like mutagenicity[4] and genotoxicity[5] with associated outcomes
such as tumorogenicity[6], and carcinogenicity[7].
The mechanism by which these organic nitrocompounds get converted into
harmful compounds is still unclear. A large number of drugs and harmful substances are
known to be detoxified by cytochrome P450 enzymes (CYP) in the liver where they are
metabolized and excreted later on [8]. For example, atorvastatin (Pfizer trade name:
Lipitor) which is a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase
inhibitor, is mainly metabolized by cytochrome P450 3A4[9]. There is also enough
evidence that P450 enzymes convert drugs and xenobiotic substances to harmful
substances. The study of activation of nitroalkanes by cytochrome P450 and cytochrome
P450-like metalloenzymes is of interest in this regard.
Nitroalkanes are perceptibly acidic compounds. The dissociation of a proton
from a nitroalkane produces the nitroalkane anion, or nitronate, which have considerably
different chemical and physical properties from those of the parent nitroalkane [10].
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Previous research has shown how cytochrome P450 enzymes transform nitroalkanes into
reactive substances [11]. The present study investigates the catalytic reduction of
nitroalkanes by the oxygenase domain of iNOS and eNOS (iNOSoxy and eNOSoxy
respectively), which also have a structural similarity to P450 metalloenzymes. Also, we
explored if there is any correlation between the extent of NOSoxy-mediated
electrocatalytic reductions of nitroalkanes and their effect on the inhibition of the NOS
catalytic reaction by iNOSoxy and eNOSoxy.
Traditional methods of enzyme activity study include assays to determine initial
rates or transient kinetics using techniques such as spectrophotometry, light scattering,
fluorometry, chemiluminescence, calorimetry,

chromatography and

radiometric

analysis[12]. These methods can resolve enzyme mechanisms in the concentration and
time domains by measuring the concentration change of the substrate or product versus
time.
The catalytic reduction of nitroalkanes mediated by NOSoxy, as well as the NOS
enzymatic reaction, both involve electron exchanges. Electrochemical methods can
therefore be used to monitor these catalytic reactions. Electrochemical methods have the
advantages of being sensitive, and relatively straightforward. To this end, we used the
surfactant film methodology[1] [13], to immobilize iNOSoxy and eNOSoxy
metalloproteins on the surface of pyrolytic graphite (PG) electrodes. We use this system
to study iNOSoxy- and eNOSoxy-mediated catalytic reduction of nitroalkanes[14, 15].
In biological systems, enzymes such as cytochrome P450s (CYPs) use electron donors
such as NADPH or NADH to perform their enzymatic activity. Direct electrochemical
methods such as the surfactant method circumvent this need by providing reducing
equivalents to the metalloenzymes directly from the underlying solid electrode [16, 17].
We could thus study the enzymatic reactions by monitoring electron flow directly from
the electrode in the presence of varying amounts of substrate.
We used this method to study the electrocatalytic reduction of nitroalkanes
mediated by iNOSoxy and eNOSoxy to derive corresponding Km and kcat values. We
compared and contrasted the catalytic data in light of the inhibitory effect of various
2

nitroalkanes on the NOS reaction as catalyzed by iNOSoxy and eNOSoxy. The
nitroalkanes we considered in this study are the three basic aliphatic nitro compounds:
nitromethane, nitroethane, and nitropropane.
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PROTOCOL FORTHE EXPRESSION AND PURIFICATION OF
INDUCIBLE AND ENDOTHELIAL NITRIC OXIDE SYNTHASE
OXYGENASE DOMAIN (iNOSoxy and eNOSoxy)
The recombinant nitric oxide synthase oxygenase domain of (iNOSoxy or
eNOSoxy) was purified from Escherichia coli using previously published protocols
[18]. The Escherichia coli culture with the cDNA encoding iNOSoxy or eNOSoxy is
grown in Terrific Broth (TB) medium in flasks that were previously autoclaved.
The seed culture was grown at 37oC supplemented with ampicillin. When the
cells reached an appropriate density, the expression of the recombinant protein was
induced by adding isopropyl--D-thiogalactopyranoside (IPTG). After 10-12 hours, the
cells were harvested by centrifugation at 40oC and resuspended in the lysis buffer. The
cells were repelleted, resuspended, and then sonicated to release the protein expressed.
The suspension is centrifuged and the supernatant was collected. Ammonium sulfate
(0.3mg/ ml volume of the protein) was used to precipitate the proteins out of the
mixture. The suspension is centrifuged to collect the precipitated protein into pellets.
Histidine-Tag affinity chromatography was used to separate the iNOSoxy or eNOSoxy
from the protein mixture. The protein solution obtained was dialyzed overnight and then
concentrated as needed. The concentration of the enzyme was determined using the
P450 assay [19]. EPPS (3-[4-(2-Hydroxyethyl)-1-piperazinyl] propanesulfonic acid)
buffer was taken as blank and iNOSoxy or eNOSxoy in EPPS buffer was used as
sample. Absorption at the Soret band at 420 nm is first recorded. The cuvette is then
saturated with carbon monoxide and then reduced using sodium dithionite.

The

resulting Fe2+state of eNOSoxy or iNOSoxy forms the carbonyl complex that is
quantified at 444 nm using know extinction coefficient. The typical concentration of the
protein in our preparations was about ~120 uM

4

Determination of the enzymatic activity by using Griess assay:
The activity of the enzyme was determined using the Griess assay[20]. All the
reaction ingredients needed for the formation of NO (i.e. H4B and the substrate Nhydroxy-L-arginine (NOHA) were added first). The reaction was triggered by adding
H2O2 and then, catalase was added to stop the reaction after a desired period of time
(typically 12-15 min). The reaction mixture was stored on ice until it was analyzed. The
nitric oxide formed is spontaneously converted to nitrite (NO2-) as a stable end product.
The Griess reagents, sulfanilamide and N-1-napthylethylenediamine dihydrochloride
(NED), are added to convert the nitrite present to a red-pink colored diazo compound
that is quantified using UV-vis[21]. The specific activity for iNOSoxy was around 63.5
nmol (NO).min-1.nmol (enzyme)-1 and 2.20 nmol (NO).min-1.nmol(enzyme)-1 for
eNOSoxy.
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CHAPTER I
NOS OXYGENASE MEDIATED NITROALKANE ELECTROREDUCTION

1.1 Introduction
Nitroalkanes are widely used substances for a variety of industrial applications.
They are used as fuel with methanol and paraffins by drag racers and hobbyists, in the
manufacture of explosives more powerful than dynamites, in the pharmaceutical
industry, and in the manufacture of pesticides, fungicides, vinyl inks, adhesives and
electrostatic paints[22]. Primary and secondary nitroalkanes act as excellent building
blocks for the synthesis of complex molecules. Hence, they are used for the synthesis of
larger complexes in a variety of reactions[23].
While organic nitrocompounds have a variety of applications, their toxicity is not
well understood, and many aspects of their interaction with biological systems need
close examination. They are considered a serious environmental hazard and are often
released into the environment through spills, transportation, and as emissions from cars.
When inhaled, these compounds are detrimental to human health. While acute exposures
are not a major risk, chronic or prolonged exposure can lead to induced
methemoglobinemia[24]. This results in the decreased oxygen carrying capacity of
blood and causes headache, nausea, vomiting, and convulsions. Although the type of
toxicity is compound-speciﬁc, the reported toxicological effects are mutagenicity[4] and
genotoxicity[5] with associated outcomes such as tumorogenicity[6], neuropathy[25],
and carcinogenicity[1].
6

To deal with xenobiotic compounds that inevitably find their way into tissues,
animals have evolved systems to eliminate these toxic compounds. Enzymatic systems
within the human body often remove the xenobiotic harmful substances by converting
the lipophilic chemical compounds into hydrophilic products that are readily excreted.
[26]. These reactions often detoxify poisonous compounds; however, in some cases, the
intermediates of xenobiotic metabolism can themselves be the cause of toxicity.
1.2 Cytochromes P450:
Cytochromes P450 (CYPs) are a gene superfamily of heme proteins found in all
eukaryotes, most prokaryotes, and archaea. They are known to metabolize a wide array
of

organic

molecules[8].

CYPs

use

a

variety

of

small

and

large molecules as substrates in enzymatic reactions. The term P450 is derived from
the spectrophotometric peak at the wavelength of the absorption maximum of the
enzyme (450 nm) when it is in the reduced state and complexed with carbon monoxide
(CO)[27]. Previous studies have shown that the nitroalkanes can be converted into
harmful substances by CYPs[1].
Cytochrome P450s can be classified into many classes [6, 28] including but not limited
to microsomal, mitochondrial, and bacterial P450 systems,
Most CYPs can metabolize multiple substrates and are involved in multiple
reactions. this enables them to catalyze the transformation and degradation of a large
variety of molecules[28]. The cytochromes P450s constitute a large family of cysteinatoheme enzymes, and play a key role in the oxidative transformation of endogenous and
exogenous molecules[23]. In all these cysteinato-heme enzymes, the prosthetic group is
an iron (III) protoporphyrin-IX coordinated to the protein by the sulfur atom of a
proximal cysteine ligand (Figure 1.1). P450 reactions of biological significance include
steroid biogenesis, drug metabolism, procarcinogen activation, xenobiotic detoxification
and fatty acid metabolism[29].

7

Figure 1.1 Cysteinato-iron(III)protoporphyrin-IX prosthetic group in P450s

Under aerobic conditions, P450 enzymes activate molecular oxygen, insert one
of the oxygen atoms into a substrate (RH in Scheme 1.1), and reduces the second
oxygen to a water molecule, utilizing two electrons that are provided by NAD(P)H via a
reductase protein[30]. Since only one of the two oxygen atoms initially present in O2
remains in the oxidized substrate, P450s are called monooxygenases. Molecular oxygen
itself is unreactive toward organic molecules at low temperatures due to high kinetic
barrier. Consequently, living systems mainly use enzymes that can activate dioxygen
and performs the desired oxidation reactions. This modification can be achieved by
metal-dependent

oxygenases,

like

cytochromes

P450

and

other

non-heme

metalloenzymes (e.g., methane monooxygenase), or by flavin-containing enzymes that
do not possess a metal-based prosthetic group[31].
8

Scheme 1.1 Cytochrome P450–redox partner electron-transfer complex

However, not all xenobiotic compounds take the oxidative metabolic pathway.
Some nitro-compounds can be reductively activated by cytochrome P450s.
Nitrocompounds can either be reduced or oxidized depending on the enzyme involved.
They can be reduced by cytochrome P450s through catalytic electron transfer[32].

9

1.3 Nitric Oxide Synthase:
Nitric oxide synthases have been the subject of intensive studies[33]. The mode
of action, distribution in different tissues, organs and species as well as comparisons
between the function of the three known isoforms at the molecular level has been the
main focus. More than 30,000 papers have been published in the past 10 years related to
Nitric Oxide Synthases (NOSs). NOSs are the enzymes responsible for the synthesis of
nitric oxide (NO) from L-arginine in mammalian tissues. These enzymes are remarkable
for the complexity of the catalytic reactions they carry out and the range of physiological
roles in which they are involved[34]. NOSs play a crucial role in the control of blood
flow, memory, and the immune response.

10

Figure 1.2 Inducible Nitric Oxide Synthase dimer (PDB database entry# 3E7T).

Figure 1.3 Endothelial Nitric Oxide synthase (Dimer) (PDB database entry#
1NSE).

NOSs are modular enzymes that consist of an N-terminal oxygenase domain
(Figures 1.2 and 1.3) and a C-terminal reductase domain. Catalysis takes place at a
cysteinyl sulfur-coordinated heme in the oxygenase domain. The heme iron binds O2 as
a sixth ligand in the distal pocket, which also serves as the site for substrate binding. In
close proximity, tetrahydrobiopterin (symbolized as H4B) is bound as an additional
cofactor. The required electrons are provided by the reductase domain, which shuttles
11

electrons from NADPH to the heme via two flavin cofactors, one FAD moiety that
accepts electrons two at a time from NADPH, and one FMN moiety that transfers them
one at a time to the heme catalytic center [35] (Scheme 1.2). The two domains are
separated by a short amino acid sequence that binds calmodulin (CaM) to enable
interdomain electron transfer. NOS is only active as a homodimer, because electron
transfer can only occur from the reductase domain of one subunit to the oxygenase
domain of the second subunit.

Scheme 1.2 General electron transfer pathway during the NOS reaction [31]
There are three distinct isoforms of NOS, which differ both in their structure and
function. Endothelial NOS (eNOS), neuronal NOS (nNOS) and inducible NOS (iNOS)
12

[36]. The three NOS isoforms are characterized by regions of high homology, but at the
same time each isoform exhibits distinctive features that reflect its specific function. The
Ca2+ -activated calmodulin in all nitric oxide synthases plays an essential role in
dimerization. In its absence, NOS exists as monomers. Dimerization is also supported by
the substrate arginine and by the tetrahydrobiopterin cofactor. The X-ray crystal
structures of NOS oxygenase domains confirmed that the heme is bound to a proximal
cysteine thiolate ligand, akin to the family of P450 enzymes (Figures 1.2 and 1.3).
Evidence obtained from studying the fluorescence dynamics of flavins suggests that the
heme is also essential in the interaction between the reductase and oxygenase domains,
which form an interface in the quaternary structure[37].

1.4. Similarities between nitric oxide synthases and P450 enzymes:
The Nitric oxide synthases shows some similarities and at the same time, exhibit
striking differences with P450 enzymes. Strictly speaking, the label cytochrome P450
stands for a widely distributed group of closely related functional enzymes that also
have common structural features, including the heme-cysteine thiolate ligation. Only in
this limited structural sense NOSs are similar to the P450 family. Also, a superficial
resemblance may stem from the fact that NOSs catalyze mono-oxygenation steps of its
substrate. The most striking among the similarities between P450 and NOS is the fact
that both the NOS oxygenase domain (NOSoxy) and mammalian (microsomal) P450
utilize the same electron donor as a redox partner. Whereas the oxygenase domains of
iNOSoxy and P450 are relatively unrelated, the reductase domain (NOSred) and
cytochrome P450 reductase (CPR) share 60% sequence homology[38]. In contrast to
most P450s, active NOS enzymes are dimeric. Despite the sequence homologies, there
are a number of notable differences between NOSred and CPR. Specifically, NOS is
equipped with a number of insertions and extensions that are specific for NOS, and that
vary between the isoforms.
13

Structural elements of nitric oxide synthases like the calmodulin binding
sequence at the N-terminal of the reductase domain, the C-terminal NADPH binding
site, the FMN domain and the small insertions between FAD and FMN domains form
the core of the reductase domain of nitric oxide synthases and show similarities with
cytochrome P450 reductase enzymes.
Spectroscopically, the similarities between NOS oxygenases (NOSoxy) and
P450s, or rather between their respective heme prosthetic groups, outnumber the
differences. Whereas most oxyferrous complexes of thiolate-ligated hemoproteins
including P450 have Soret maxima at about 418 nm [39], the corresponding peak for
NOS is usually at 428 nm, although a more P450-like position at 418nm is observed
under some conditions. This difference in the position of the Soret band of the
oxyferrous complex could be a prominent distinction. It is not yet clear what is causing
the remarkable red shift and why it is sometimes absent. Based on these similarities and
differences, it is worthwhile to explore to what extent nitric oxide synthases can act like
P450s in activating nitroalkanes. In a related aspect, we would like to know to what
extent nitroalkanes interfere with and inhibit the molecular function of NOSs and nitric
oxide synthesis.

14

CHAPTER II

iNOSoxy AND eNOSoxy MEDIATED NITROALKANE ELECTROREDUCTION

2.1. Introduction
Nitroalkanes are considered a serious hazard both to the environment and to
human health. While acute exposures are not a major risk, chronic or prolonged
exposure can lead to adverse reactions and an onset of pathological conditions, including
decreased oxygen carrying capacity of blood with symptoms such as headache, nausea,
vomiting, and convulsions [40].
Nitroalkanes are electroactive and can be converted to the corresponding
hydroxylamines and amines by a series of proton-coupled electron transfers. This
reduction can be catalyzed by heme or heme-proteins as shown in scheme 2.1.

15

Scheme 2.1 Conversion of nitroalkanes to corresponding hydroxylamines [41]
Previous studies show that the P450 enzymes can convert nitroalkanes into
hydroxylamines[42]. The electrons required for the reaction are provided by the
flavoprotein reductases.
Nitric oxide synthases (NOSs) exist as homodimers. Each monomer consists of
two major regions: an N-terminal oxygenase domain with a heme-thiolate catalytic
center, and a multi-domain C-terminal reductase domain, which is homologous to P450
reductases and other flavoproteins. The reductase domain contains FMN and FAD
binding subdomains and a binding site for NADPH, which is the source of reducing
equivalents. The interdomain linker between the oxygenase and reductase domains
contains a calmodulin-binding sequence. The oxygenase domain is a unique extended
beta sheet cage with binding sites for heme and a pterin cofactor. Binding of calmodulin
appears to act as a "molecular switch" to enable electron flow from flavin prosthetic
groups in the reductase domain to the heme. Given the structural similarity at the heme
domain between the P450 proteins and NOSs, the catalytic reduction of nitroalkanes can
be conceptually mediated by NOSs using electrons from its flavoprotein reductase.
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2.2. Electrochemical methods and application to the study of redox proteins
P450s use electron transfers to perform the reductive activation of substrates.
Electrochemical methods can be used to monitor the transfer of reducing equivalents
that drive the catalytic reaction. Usually, redox partners are needed in electron-driven
catalytic transformations. However, the electrode surface can play the role of electron
source, which also provides a means to monitor the corresponding catalytic reductions.
Efficient coupling of the large biological enzyme to the electrode surface is critical for
this type of electron transfer to happen. In fact, direct electron transfer to large
biomolecules such as proteins and enzymes at an ordinary electrode surface is usually
very slow. However, this barrier may be overcome by using redox promoters such as
conjugated and aromatic organic molecules [13], by directly tethering the redox proteins
to electrode surfaces, or by embedding them in thin films on electrodes.
Electrochemical methods comprise a collection of useful measurement tools. A
central feature of these methods involves an electrode that provides an interface where
some form of charge-transfer process occurs. This charge-transfer process is
characterized by potential and/or current signals that can be measured and used to
monitor coupled chemical processes in the immediate vicinity of the electrode surface.
Broadly speaking, electrochemical methods can be divided into two groups:
measurements that do not involve current, known generally as potentiometric methods,
and measurements that involve current flow at an electrode under potential control.
During an electrochemical measurement, the oxidation and reduction of the
solution components at the surface of the electrode, gives an electric signal which is
used to derive information redox entities in the immediate vicinity of the electrode.
When a molecule undergoes oxidation at the electrode surface, electrons flow from the
molecule into the electrode material, is measured in the form of electrical current that
reports on the magnitude of the electron exchange. While in an electrochemical
reduction, electrons flow from the electrode to the analyte of interest. Therefore, the
electrode can be viewed as either an oxidizing agent or a reducing agent, depending on
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the direction of current flow, which is a result of the imposed potential and the nature of
the analyte near the electrode.
Cyclic voltammetry (CV) is widely used in electroanalytical studies and
mechanistic investigations. As the name implies, the potential is swept from an initial
potential to a final potential and then returned to the initial or to a different potential,
usually at the same scan rate. The current measured continuously during the scan is
reported against the applied potential. Hence, the technique provides voltammetric
information (current vs. potential) about the substance in contact with the electrode and
the various chemical processes that are triggered by electron transfers to or from the
electrode. This is useful for both qualitative and quantitative identification and also for
the detailed mechanistic study of electron-driven chemical and catalytic transformations.
CYP enzymes use NADPH or NADH as electron donors to perform their
enzymatic activity. As stated above, if enzymes such as CYP can be connected to solid
electrode surfaces by a bridge or other promoters, electrons can be exchanged with the
underlying electrode, thus shortcutting the need for soluble electron donors or mediators
in the system. We can thus study enzymatic reactions by providing the electrons directly
from the electrode. The current response on the electrode is directly related to the rate of
the reaction and the amount of substrate being processed. In this dynamic technique,
thermodynamic information on the active site of the enzyme is obtained from electrode
potential, and information on enzymatic kinetics is obtained from the current. When
direct electron transfer to large redox proteins and enzymes on an electrode is possible,
the amount of sample needed can be very small; this is a direct result of the high
sensitivity of electrochemical techniques.
Direct electrochemistry can be a very useful tool for the study of the properties
of proteins and the nature of reactions in which they participate. As hinted above, direct
electron transfer to large redox proteins is often slow due to many reasons. One reason is
the fact that the electroactive group is often buried within the protein shell. Denaturation
of proteins and adsorption of protein debris on the electrode surface is another reason
that slows down the direct electron transfer. The unfavorable orientation of the protein
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and the electroactive group embedded within it may be a third reason for the sluggish
direct electron exchange. Here the heme group in the nitric oxide synthase is relatively
buried within the protein, which prevents its direct interaction with the electrode surface
for electron transfer [43]
A general approach to enhance the rate of direct electron transfer to large
biomolecules such as proteins is to couple them to the electrode surface with molecular
wires (i.e. conjugated molecules) or affix them in thin films or layers that facilitate
electron exchange. Methods such as self-assembled monolayers, biocompatible polymer
films, surfactant bilayers, redox nanoparticles, and polyelectrolyte layer-by-layer films
have been applied to immobilize redox proteins at the electrode surface [44]. One
method that proved to be versatile and straightforward is the surfactant film
methodology[45]. Due to low concentration of protein samples used, methods that allow
the formation of multiple layers and increase the effective electroactive proteins near the
electrode surface are of interest. Such configuration is offered by the multiple layers of
surfactant film which trap a relatively large amount of the redox protein under
consideration[43].

In

the

past,

we

have

used

surfactants

such

as

didodecyldimethylammonium bromide (ddab) or phosphatidylcholine derivatives, which
provide thin stable films as a microenvironment for enhanced electron transfer with the
redox protein[45]. Particularly, ddab film forms ordered bilayer structures, and provides
a configuration which can increase the protein concentration at the electrode interface
and also facilitates appropriate orientation for electron exchange[17]. At the same time,
the ddab films allow for the needed exchange of electrolytes with the solution during
electrochemical reactions.

2.3 Protein immobilization method
Before the development of biomolecule immobilization methodologies,
electrochemical studies of redox proteins and enzymes were carried out in solution and
the signal obtained directly at the working electrode was very slow. In other cases
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electron exchange was facilitated by small redox mediators[46]. This approach requires
large amounts of precious protein samples and, with the quality of current signal
obtained from the slow electron transfer it is impossible to gain useful kinetic or
thermodynamic insights. The protein immobilization method confines the protein on the
surface of working electrodes instead of having a protein in solution. This approach not
only saves a lot of protein sample, but also enhances the electrochemical signal. The
early feasibility of direct (non-mediated) electron transfer to and from redox proteins
spurred electrochemical investigations of metalloproteins and other redox proteins in
many directions, and opened valuable doors for the thermodynamic and kinetic studies
on electron-driven enzymatic reactions. In addition to enhanced electrochemical signals,
the advantages of enzyme immobilization on electrodes include reduced cost and ease of
studying the effect of experimental parameters such as pH, as well as the effect of
solution-based cofactors and reactants by just dipping the modified electrode in various
solutions.
Enzymes and other redox proteins can be attached to an electrode by interactions
ranging from reversible physical adsorption and ionic linkages, to entrapment in thin
films and lipid bilayers, to more sturdy covalent bonds. Techniques using surfaceconfined metalloproteins, especially enzymes, at electrode interfaces may not only
provide means to construct substrate-specific biosensors and bioreactors, but can also be
used to study enzymatic activity of metalloenzymes. The covalent attachments
commonly used include amide, ether, thio-ether, or carbamate functionalities.

2.3.1 Formation of covalent bonds
Immobilization of redox proteins through the formation of covalent bonds is well
established. An advantage of these methods is that specific reactive residues can be
introduced and targeted to allow appropriate orientation of the biological entity on the
electrode surface. The targeting approach also helps to avoid alteration of essential
catalytic domains or residues.
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The array of reactive groups allowing covalent tethering of enzymes and redox proteins
to electrodes and matrices is large and dictated by the nature of the redox protein and
electrode interface. Chemical coupling of enzymes and redox proteins to polymeric
matrices with reactive functional groups is another mode of covalent attachment. The
polymeric matrices can covalently attach to the protein of interest on one hand, and react
with complementary functionalities on the electrode on the other. Self-assembled
monolayers (SAMs) is another method in which alkane thiols spontaneously form on
electrode materials such as Au, Pt, and Ag forming stable sulfur-metal bonds [47].
Introduction of appropriate functional groups at the end of these molecular wires provide
another method that is used to covalently attach protein molecules. With this
configuration and with the right choice of reactive functional groups, one can
electronically couple redox proteins of interest with the electrode surface[48].

2.3.2 Adsorption
Another method for the immobilization of proteins is protein adsorption. Proteins
adsorb ubiquitously on solid electrode surfaces either as such or with the aid of an
appropriate primary adsorbate. The adsorbate forms a layer between the protein and the
electrode. The control of the conditions during adsorption is of importance and dictates
the extent of coupling and electron exchange with the protein at the surface.

2.3.3 Entrapment in thin films
Entrapment of a redox protein or enzyme within a polymeric network or a thin
lipid film allows limited diffusion within the film and intimate communication with the
underlying electrode surface. This method differs from the coupling methods, in that the
enzyme is not specifically bound to the electrode, matrix, or membrane. However,
because of preferred orientations in the film and limited diffusion, the redox protein is
able to efficiently exchange electrons with the electrode surface.
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2.3.4: Lipid bilayered thin films
Although artificial and may not reflect the native environment for particular
enzymes, proteins in lipid films is no innovation but an inspiration from biomembranes
in living organisms, which usually are arranged into bilayers with embedded functional
proteins. Surfactant molecules is an example and can form ordered bilayers with
properties similar to biomembranes. The direct electrochemistry of redox proteins in
these biomembrane-like films provides a good model for the study of redox processes in
biological systems. Amphiphilic compounds such as didodecyldimethylammonium
bromide (ddab) form a water-insoluble bilayered film structure that resembles biomembranes on solid electrode surfaces. Both hydrophilic and hydrophobic proteins or
other molecules can be embedded into these thin films[49]. Surfactant ddab and other
similar surfactants have proven to form excellent lipid microenvironments for the
immobilization of many redox proteins for enhanced electron transfer. Some early
examples include myoglobin[1], hemoglobin[50], catalase[51], cytochrome P450cam,
cytochrome P450 CYP119, cytochrome P450st30, cytochrome P450BM3, to cite a few.
The electrochemical response of these proteins is significantly enhanced compared with
bare electrodes. The increased electrochemical response has been ascribed to the fact
that the proteins are able to diffuse rapidly through the surfactant film. The ddab
surfactant prevents the macromolecular denaturation and the adsorption of the denatured
protein on the electrode surface, which can block electron transfer.

NOS oxygenases in surfactant films: The heme in NOS oxygenases (iNOSoxy, eNOSoxy,
etc.) undergoes redox changes. Our lab has previously shown that immobilization of NOSoxy
proteins in thin surfactant and other types of films on solid electrodes provides a
microenvironment for electron exchanges between NOSoxy and the underlying electrode[45].
Our early studies have shown that this system allows for the study of both the kinetic and
thermodynamic aspects of redox changes of NOSoxy proteins. As we stated earlier, the lipid
bilayer structure provides a biomembrane-like environment in which the protein molecule is
trapped while preserving its native structure. We use this configuration to characterize the redox
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activity of the heme group in NOS oxygenases and analyze the responses in the absence and
presence of nitroalkanes as substrates for catalytic reductions mediated by NOS oxygenases.

2.4. Method
All electrochemical experiments are conducted in a three-electrode system on a
BAS 100B electrochemical workstation or a CH Instrument. Ag/AgCl (1M KCl) is used
as reference electrode and all potentials are reported versus this reference. A platinum
wire is employed as the auxiliary electrode and protein-modified pyrolytic graphite (PG)
electrodes are used as working electrodes. Unless specified, all experiments are
performed in 0.1M acetate buffer (pH 5.5) containing 0.1M sodium bromide. The
solution in the cell is purged with purified nitrogen for at least 15 min prior to
electrochemical measurements to remove oxygen from the solution. A nitrogen blanket
is maintained to prevent the reentry of oxygen from air[52]. Stirring is maintained
between scans [53].
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Figure 2.1

The three-electrode electrochemical cell used the voltammetric

characterization of NOSoxy-modified electrodes

2.4.1 Materials
iNOSoxy was expressed and purified as described in the protocol for protein
purification. Didodecyldimethylammonium bromide (ddab) and all nitroalkanes are
from Acros Organics. Nitrogen gas is purchased from PRAXAIR. Deionized water with
a resistivity greater than 18 MΩ·cm is obtained from a Barnstead Nanopure system and
pyrolytic graphite (Advanced Ceramics) is the material used to make working electrodes
as described below.
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2.4.2 Fabrication and modification of working electrodes
Pyrolytic graphite (PG) electrodes are constructed are follows. A cylinder of PG
was cut perpendicularly to the basal plane from large block using a diamond core drill
bit with a diameter of 3 mm as shown in Figure 2.2. A small incision was made on one
side of the cylinder for electrical connection with a copper wire which was connected
using equal volumes of conductive epoxy and allowed to dry for 24 hours. The graphite
cylinder was then inserted into a glass tubing and set in place with non-conductive
epoxy and allowed to dry. The non-conductive epoxy was also used to seal the gaps
between graphite and glass. The finished electrode was then polished and cleaned as
follows: the PG electrode is first polished using 400-grit sandpaper until a fresh basal
surface was exposed. The surface of the electrode was then polished successively with
1μm, 0.3μm and 0.05μm alumina slurries. Finally, the electrode is rinsed and briefly
sonicated in distilled water to remove any attached alumina particles.
An emulsion of the surfactant is prepared by dissolving enough ddab powder in
deionized water to make 10 mM final concentration. The emulsion was then sonicated
for at least 2 hours or until the solution becomes clear. A mixture of 10 l of 10 mM
ddab and 10l of iNOSoxy or eNOSoxy was cast on the electrode surface and the
electrode was stored with a cover for 12 hours and then open for another 12 hours at
4oC.
.
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Figure 2.2 Fabrication of pyrolytic graphite electrode
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2.5 Results and Discussion
2.5.1 Direct electron transfer to iNOSoxy in surfactant films on pyrolytic graphite
and catalytic reduction of nitromethane
Rusling’s surfactant films such as ddab films have been employed in the
immobilization of many heme proteins, notably myoglobin, hemoglobin and catalase.
By immobilizing the proteins on the electrode surface, the electron transfer is
significantly enhanced. We used this thin film methodology for the study of redox
properties of NOSoxy proteins and to monitor their catalytic reduction of
nitroalkanes[45].
Figure 2.3 shows the typical cyclic voltammogram of iNOSoxy in ddab
surfactant film in 0.1M acetate buffer at pH 5.5. The voltammogram shows two redox
III

couples. The first redox couple (R1/O1) is assigned to the reversible reduction of Fe to
II

Fe of the heme center, and occurs at a potential –0.180 V vs. Ag/AgCl (Equation 1).
II

I

The next couple (R2/O2) is assigned to the reduction of Fe to a formal Fe state and
occurs around –1.052 V vs. Ag/AgCl (Equation 2). Control experiments with the ddabonly modified pyrolytic graphite electrodes show no redox peaks in the same voltage
window.
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Figure 2.3 Cyclic voltammogram of iNOSoxy in ddab on PG electrode at pH 5.5 in
acetate buffer at a Scan rate of 0.1V/s.
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2.5.2 Electrocatalytic reduction of nitromethane catalyzed by iNOSoxy
The cyclic voltammogram of iNOSoxy as described above dramatically changes
after adding nitromethane. Upon addition of nitromethane, an irreversible peak, R3,
II

I

appears at -1.0V vs. Ag/AgCl in parallel with the disappearance of the Fe /Fe redox
couple[54]. Control experiments on ddab/PG electrodes without iNOSoxy under the
same conditions do not show the peak R3, which rule out direct reduction of
nitromethane at the electrode surface. The R3 peak current is significantly higher and
with a peak potential that is more positive than the R2/O2 redox peak. The normalized
peak current of R3 peak (peak current of R3 divided by the current of R1) decreases as
the scan rate increases. All of these characteristics confirm that the new R3 peak is a
result of the catalytic reduction of nitromethane mediated by iNOSoxy. A similar
finding was reported earlier for myoglobin[1]. The peak shape of the catalytic wave, R3,
is a result of substrate depletion in the film during turnover and subsequent
replenishment by diffusion from the bulk.
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Figure 2.4 Cyclic voltammetry of iNOSoxy in ddab on PG electrode in absence and
presence of nitromethane.
2.5.3 Effect of nitromethane concentration:
We compared the iNOSoxy-mediated electroreduction of nitromethane at
increasing concentrations ranging from 0.2 mM to 2.0 mM. The catalytic current at the
peak R3 increases with increasing concentration of nitromethane as expected for an
electrocatalytic process (Figure 2.5).
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Figure 2.5 Cyclic voltammograms of iNOSoxy in ddab film on PG electrode
in the presence of increasing nitromethane concentrations
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Figure 2.6 Comparison of catalytic efficiencies as a function of nitromethane
concentrations in acetate buffer at pH 5.5

One way to monitor the catalytic turnover in this system is to measure the
catalytic current and compare it to the current of a monoelectronic peak such as the
reversible peak of Fe3+/Fe2+ redox couple (R1). The ratio of the catalytic peak current
(R3) to the reversible current of (R1) defines the catalytic efficiency, which can be used
to compare the rate of iNOSoxy-mediated reduction of nitromethane at different
concentrations. The catalytic efficiency (IR3/IR1) initially increases and then to curves
down with a shape typical of enzyme saturation kinetics (Figure 2.6). Such behavior can
therefore be described using the Michaelis Menten model (vide infra: nonlinear fitting
section).
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2.5.4. Effect of scan rate:
We analyzed the effect of scan rate on the iNOSoxy-mediated catalytic reduction
of nitromethane. In cyclic voltammetry, increasing the scan rate shortens the timescale
within which the catalytic reaction is monitored; as a result the number of catalytic
turnovers decreases. As expected, the catalytic efficiency, defined by the ratio (IR3/IR1) is
larger at smaller scan rates and gradually drops as the scan rate increases[30]. As shown
in Figure 2.7, the increase of scan rate results in a decrease in the catalytic efficiency
R3/R1.
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Figure 2.7 Catalytic efficiency in the presence of 0.8 mM nitromethane as a
function of scan rate
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Figure 2.8 Cyclic voltammograms of iNOSoxy in ddab film on PG electrode
at various scan rates.
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2.5.5 Peak Potentials:
The peak potentials at R1 and O1 redox couple were observed at different concentrations
of nitromethane. There was no significant change in the peak potential at the R1/O1 with
varying concentrations of nitroalkanes indicating that there was no significant
interaction of the nitroalkanes with the Fe3+/Fe2+ redox couple[1].

We plotted the peak potential of the catalytic wave as a function of scan rate. Figure 2.9
shows that the catalytic peak shifts negatively with increasing scan rate. Also, the figure
shows that there is an overall negative shift of peak potentials as the concentration of
nitromethane is increased. Since we have shown that the iNOSoxy-FeII-heme potential is
not affected by the presence of nitromethane, the negative shift of potentials cannot be
rationalized in terms of substrate binding to the FeII-heme catalytic center.

-1.04

-1.06

V vs. Ag/AgCl

0.3 mM
-1.08

-1.10

0.8 mM

-1.12

-1.14

1.3 mM
-1.16
0.00

0.05

0.10

0.15

0.20

log (Scan rate, V/s)

Figure 2.9 Effect of scan rate on the potential of the catalytic peak R3
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2.5.6 Comparison of the electroreduction of different nitroalkanes by iNOSoxy
in ddab surfactant films

2.5.6.1 Effect of the nitroalkane concentration:
By comparing the catalytic reduction of three nitroalkanes: nitromethane,
nitroethane and nitropropane, we show that all nitroalkanes share a common catalytic
feature: As the concentrations of the nitroalkanes increase, there is an increase in the
catalytic wave R3. However, the rate and extent of increase differs from one nitroalkane
to another. Catalytic efficiency was the criterion used to compare the rate of iNOSoxymediated reduction of the various nitroalkanes. For all nitroalkanes, the catalytic
efficiency initially increases and then curves down with a shape typical of enzyme
saturation kinetics. Such behavior can therefore be described using the MichaelisMenten model (vide infra: nonlinear fitting section).
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Figure 2.10 Catalytic efficiency of iNOSoxy-mediated catalytic reduction of the various
nitroalkanes as a function of concentration.
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2.5.6.2 Catalytic efficiency versus scan rate:
As described above, the catalytic efficiency tends to decrease with an increase in
the scan rate. The reason being the time scale for the reaction tends to decrease with the
scan rate resulting in the decrease in the number of catalytic turnovers.

200

catalytic efficiency IR3/IR1

180

160

Nitroethane
Nitropropane

140

120

Nitromethane
100

80
-1.5

-1.4

-1.3

-1.2

-1.1

-1.0

-0.9

-0.8

-0.7

log (scan rate, V/s)

Figure 2.11 Catalytic efficiencies of iNOSoxy-mediated reduction of the various
nitroalkanes as a function of scan rate
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2.5.7 Redox properties of eNOSoxy in surfactant films on PG
electrodes and eNOSoxy-mediated catalytic reduction of nitromethane
Like in the iNOSoxy case, surfactant film ddab was employed in the
immobilization of eNOSoxy on the surface of the electrode. [45]. A typical
voltammogram of eNOSoxy is shown in Figure 2.12. We observe two redox couples:the
III

II

first redox couple (R1/O1) is assigned to the reversible reduction of Fe to Fe of the
heme center (Equation 3), and the next couple (R2/O2) is assigned to the reduction of
II

I

Fe to a formal “Fe ”(Equation 4)

R1/O1
eNOSoxy/FeIII - +1e-1

eNOSoxy/FeII

(3)

“eNOSoxy/FeI”

(4)

R2/O2
eNOSoxy/FeII - +1e-1
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Figure 2.12 Cyclic voltammetry of eNOSoxy/ddab/PG at pH 5.5 in acetate
buffer at scan rate 0.1V/s.
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2.5.7.1 Electrocatalytic reduction of nitromethane on eNOSoxy/ddab/PG:
Similar to the iNOSoxy case, the presence of nitromethane at the
eNOSoxy/ddab/PG electrode gives rise to an irreversible peak, R3 at -1.0 V vs. Ag/AgCl
II

I

in parallel with the disappearance of the the Fe /Fe redox couple[54].

6E-5
5E-5

R3/O3

0.2 mM Nitromethane

Current / A

4E-5
3E-5
2E-5
1E-5

eNOSoxy/ddab/PG

R1/O1

R2/O2

0
-1E-5
0.4

0.2

0.0

-0.2

-0.4

-0.6

-0.8

-1.0

-1.2

-1.4

V v/s. Ag/AgCl
Figure 2.13 Cyclic voltammetry of eNOSoxy in ddab on PG electrode in absence and
presence of nitromethane.

41

2.5.7.2 Effect of nitromethane concentration on eNOSoxy-mediated catalytic
reduction
As the concentration of the nitromethane added increases, there is an observed
increase in the catalytic wave R3. The catalytic efficiency initially increases and then
curves down with a shape typical of enzyme saturation kinetics.

Catalytic efficiency IR3/IR1

100
90
80
70
60
50
40
30
0.2

0.4

0.6

0.8

1.0

Nitromethane concentration /mM

Figure 2.14 Comparison of catalytic efficiencies as a function of
nitromethane concentrations in acetate buffer at pH 5.5
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2.5.7.3 Comparison of the effect of different nitroalkanes on the catalytic
efficiencies of eNOSoxy:
All the nitroalkanes in our study show that the catalytic efficiency initially
increases and then, tends to curve down with a shape typical of enzyme saturation
kinetics. Such behavior was described by using the Michaelis-Menten model.
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Figure 2.15 Catalytic efficiency of eNOSoxy-mediated catalytic reduction
of the various nitroalkanes as a function of concentration.
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2.5.8. Comparison of catalytic efficiencies of iNOSoxy- and eNOSoxymediated catalytic reduction for the various nitroalkanes:
2.5.8.1 Comparison of the effect of different nitroalkanes on the catalytic
efficiencies of iNOSoxy and eNOSoxy

As we explained in the case of iNOSoxy, the peak area of the Fe3+/Fe2+
reversible reduction is proportional to the amount of electroactive species in the film.
The surface concentration of active iNOSoxy or eNOSoxy on electrodes will be
different. This difference in surface concentrations can be a problem when comparing
the catalytic currents for different catalysts but this can be corrected by knowing the
average catalyst surface concentration using the charge integration procedure for a
typical electrode under the same conditions. As we will see later in section 2.5.9, the
exact amount of NOSoxy catalyst on the surface of the electrode is an important quantity
in order to fit the experimental points of a each case using the Michaelis-Menten
framework. For comparison purposes, however, the normalized current ratio of R3/R1
can be used to compare the catalytic turnover of eNOSoxy and iNOSoxy for a given
nitroalkane despite the difference in the absolute amounts of NOSoxy catalyst on the
surface of the electrode. Figure 2.16 shows the case of nitropropane’s catalytic reduction
by iNOSoxy and eNOSoxy, which shows relatively higher catalytic turnovers for
iNOSoxy compared to eNOSoxy.
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Figure 2.16 Comparison of the catalytic efficiencies of iNOSoxy and eNOSoxy as a
function of nitropropane concentrations in acetate buffer at pH 5.5.

45

2.5.8.2 Comparison of the catalytic efficiency as function of scan rate for eNOSoxywith iNOSoxy-mediated reduction of nitroalkanes

We compared the catalytic efficiency of iNOSoxy- and eNOSoxy-mediated reduction of
nitromethane at the same concentrations as a function of scan rate. As expected, the
catalytic efficiency, defined by the ratio (IR3/IR1) is larger at smaller scan rates and
gradually drops as the scan rate increases for both iNOSoxy and eNOSoxy (Figures
2.17, 2.18 and 2.19). However, eNOSoxy shows lower catalytic efficiencies when
compared to iNOSoxy for all nitroalkanes considered for our study (Figures 2.17, 2.18
and 2.19). The reasons for the differences could be due to the structural differences in
iNOSoxy and eNOSoxy, which we will discuss in section 3.4.

90

Catalytic Efficiency IR3/IR1

85

80

75

70

iNOSoxy
65

60

eNOSoxy
55
1

2

3

4

5

log (scan rate, V/s)

Figure 2.17 Catalytic efficiencies of iNOSoxy and eNOSoxy-mediated reduction at 0.8
mM nitromethane as a function of scan rate in V/s
46

130

Catalytic efficiency IR3/IR1

120
110

iNOSoxy
100
90
80

eNOSoxy

70
60
-1.0

-0.9

-0.8

-0.7

log (scan rate, V/s)

Figure 2.18 Catalytic efficiencies of iNOSoxy and eNOSoxy-mediated reduction at 0.8
mM nitroethane as a function of scan rate in V/s
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Figure 2.19 Catalytic efficiencies of iNOSoxy and eNOSoxy-mediated reduction at 0.8
mM nitropropane as a function of scan rate in V/s
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2.5.9 Michaelis Menten Kinetics:
The plot obtained by comparing catalytic efficiencies at different concentrations of
nitroalkanes is in essence a plot of enzymatic rates as function of concentration and
could be fit to Michaelis Menten equation (Equation 5).,

(Michaelis Menten equation)

(5)

Km represents the constant for the formation of enzyme substrate complex. Km is
equal to the substrate concentration at which the reaction rate is half its maximum value.
The value of Km for an enzyme depends on the particular substrate. The kcat value gives
the turnover number, i.e. the number of molecules of the substrate that each enzyme
molecule converts in a unit time. The higher the kcat value the more efficient the enzyme
is for the catalytic transformation under consideration. Fitting the curve of catalytic
efficiency (equivalent to the rate of enzymatic reaction) versus substrate concentration to
the electrochemical form of the Michaelis-Menten model allows us to extract the kcat and
Km values.

By measuring the currents of the iNOSoxy- and eNOSoxy-mediated catalytic
reduction of nitroalkanes and extracting enzymatic reaction parameters such as Km and
kcat, we will be able to compare and contrast the catalytic behavior of iNOSoxy and
eNOSoxy towards the nitroalkanes. The catalytic current at the NOS-modified electrode
in the presence of nitroalkanes is a measure of the rate of catalytic reduction and can be
used in an equation equivalent to the general Michaelis-Menten equation in solution.
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The Michaelis-Menten equation (Equation 6) using catalytic currents at the electrode is
of the form:

(6)
In this case, Icat is the catalytic current at the peak R3.
‘n’ being the number of electrons in the reaction.
‘F’ is the Faraday constant.
‘A’ is the area of the electrode.
‘Γ’ is the surface concentration of the enzyme, which we determine by integrating the
peak current at R1.
The surface concentration of the enzyme is required to calculate the Km and kcat
values of the enzyme in the presence of different nitroalkanes. The surface concentration
of the enzyme is determined by integration of the reduction current as shown in Figure
2.20 and Figure 2.21 at the R1 peak where the FeIII to FeII conversion takes place. The
area under the voltammogram is a measure of the charge passed during the reduction of
all accessible Fe(III) sites in the film. The charge passed is a measure of the number of
electrons transferred, and thus the number of iNOSoxy molecules present given the one
heme per iNOSoxy protein relationship. To this end, the voltammogram is obtained at a
scan rate as low as 5 mV/sec [30], which allows for the reduction of the total
electroactive protein in the film. The average surface concentration of the electroactive
iNOSoxy estimated indicates that only a small percentage of the total amount of
iNOSoxy deposited on the electrode surface was actually electrochemically reduced.
This may suggest that only those iNOSoxy molecules in the inner layers of the film
closest to the surface of the electrode and with a suitable orientation exchange electrons
with the electrode and contribute to the observed redox reaction [55].
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Figure 2.20 Integration of iNOSoxy at the Fe3+/Fe2+ redox couple; area under
the curve is a measure of the charge passed
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Figure 2.21 Integration of the area under the voltammogram at R1 of
iNOSoxy/ddab/PG taken at 5mV/s
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The Km values were extracted from the plots of catalytic efficiencies as
function of concentration of nitroalkanes through nonlinear fitting using the MichaelisMenten model (equation 6).
Figure 2.22 shows the fitting of turnovers of iNOSoxy-mediated catalytic reduction as a
function of concentration for the three nitroalkanes. The Km values of obtained are
listed in Table 2.1. Figure 2.23 shows the fitting results in the case of eNOSoxymediated catalytic reduction. The corresponding Km values are also listed in Table 2.1.
Nitropropane
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Figure 2.22 Catalytic efficiency of iNOSoxy-mediated catalytic reduction of the various
nitroalkanes as a function of concentration to obtain the Km values.
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Figure 2.23 Catalytic efficiency of eNOSoxy-mediated catalytic reduction of the various
nitroalkanes as a function of concentration to obtain the Km values.

Table 2.1 The Km Values for iNOSoxy and eNOSoxy in the presence of
nitroalkanes
Nitroalkane

Km iNOSoxy

Km eNOSoxy

(mM)

(mM)

2.9±1.4

1.44±0.37

Nitroethane

4.075±2.0

1.56±0.45

Nitropropane

6.919±2.9

0.40±0.09

Nitromethane

As stated before, Km is a measure of the substrate concentration at which the
catalytic reaction rate is half of its maximum value. The above results show that Km
values of iNOSoxy are generally higher than the Km values obtained for eNOSoxy,
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indicating that the binding affinity of the nitroalkanes to the active form of eNOSoxy is
higher than with iNOSoxy.
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CHAPTER III

EFFECT OF NITROALKANES ON THE CATALYTIC SYNTHESIS
OF NITRIC OXIDE (NO) BY iNOSoxy

3.1. Introduction:
Nitric Oxide (NO) is produced by nitric oxide synthase (NOS) enzymes from
the substrate, L-arginine (Arg). NOSs are enzymes that catalyze a two step reaction to
form citrulline and nitric oxide (NO) from L-Arg. The NO synthesis is complicated
because the catalytic assembly involves a variety of co-factors[56]. The biosynthetic
reaction consumes 1.5 NADPH molecules and two atoms of oxygen for the synthesis of
NO. The calmodulin (CaM) binding is needed for function and triggers inter-domain
electron transfer between the reduced FMN and the heme group. NADPH is the source
of reducing equivalents in the reaction.. During the catalytic cycle, electrons are
transferred from the NADPH at its binding site to the heme through FAD and FMN. A
pterin cofactor (tetrahydrobiopterin, H4B) is involved and has multiple functions during
the catalytic cycle. It promotes dimer assembly of iNOS heme-containing monomer,
increases the arginine binding affinity, modifies heme midpoint potential and induces a
high spin shift of the heme iron. The H4B ring also makes π-stacking and hydrogenbonding interactions with several conserved residues that are provided by both subunits
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of the NOSoxy dimer[57] . Although we can follow the two-step reaction using the fulllength enzyme, one can study the second step only on iNOSoxy or eNOSoxy using Nhydroxyarginine (NOHA) intermediate as the substrate. Reducing equivalents are
provided in the form of hydrogen peroxide (H2O2), which is used to trigger the catalytic
reaction.
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Scheme 3.1 Nitric Oxide Biosynthesis
In this chapter, we compared the native enzymatic activity of NOSs (in the form
of iNOSoxy and eNOSoxy) in the presence of varying concentrations of nitroalkanes
(nitromethane, nitroethane, and nitropropane). Nitric oxide synthase activity can be
assayed by either measuring the citrulline or NO itself. Formation of tritium- or

14

C-

labelled citrulline from labeled L-arginine is one of the methods[34]. Another
straightforward method, which is widely used, is to measure stable end-products of NO
in aqueous solutions, namely nitrite (NO2-) and nitrate (NO3-). The reduction of NO3- to
NO2- followed by the colorimetric Griess reaction to measure NO2- provides a
quantitative measure of NO synthesis, and thus the catalytic activity of NOS or NOSoxy
enzymes could be measured.
All the ingredients for the NOS reaction (substrate NOHA in our case, and the H4B
cofactor) are added to the reaction mixture. The reaction is triggered by adding H2O2 and
stopped after a desired amount of time by adding glacial acetic acid and transferring the
reaction tube to ice-water. The nitric oxide product (NO) in the form of nitrite (NO2-) is
quantified using the Griess assay as described in Scheme 3.2 below [21]. The Griess
assay

determines

the

amount

of

nitrite

(NO2-)

in

the

reaction

mixture

spectrophotometrically through the quantification of a stable pink color diazo
compound.

Scheme 3.2 Griess Assay

The amount of nitrite formed is essentially equal to the amount of NO produced
in the reaction mixture. Thus, the amount of nitrite (NO2-) formed can be used to
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measure the enzyme activity of iNOSoxy or eNOSoxy in terms of NO synthesis from
NOHA.
3.2 The Griess assay
The activity of an enzyme is the number of moles of the substrate converted to
product in a unit time. In this method, all the reaction ingredient needed for the
formation of NO (NOHA, H4B), were incubated with iNOSoxy or eNOSoxy in the
reaction mixture. H2O2 was used to start the reaction and catalase was added to stop the
reaction. The reaction tube is immediately transferred to ice and stored there until
analysis by the Griess assay. Sulfanilamide and NED is used for the formation of the
colored azo compound which was quantified by using uv-vis[21]. The typical specific
activity of iNOSoxy samples in the absence of nitroalkanes was found out to be 63.5
nmol(NO).min-1.nmol (enzyme)-1
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Figure 3.1 Comparison of iNOSoxy activity (NO synthesis) in the presence of
nitromethane (black solid squares), nitroethane (red solid circles), and nitropropane
(blue solid triangles) at various concentration levels. Data are averages of three trials.
Bars represent standard deviations
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3.3 Results:

Figure 3.1 shows that NO synthesis activity of iNOSoxy decreases with all nitroalkanes
in a dose-response manner. While the overall activity of eNOSoxy is typically lower
than iNOSoxy, similar trends were obtained with eNOSoxy where the activity decreases
with increase in concentration indicating that the eNOSoxy is being inhibited by the
nitroalkanes. Figure 3.2 shows the effect of nitromethane addition on eNOSoxy
enzymatic NO synthesis.
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Figure 3.2 Comparison of eNOSoxy activity (NO synthesis) in the presence of
nitromethane (black solid squares). Data are averages of three trials. Bars represent
standard deviations
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Overall, nitromethane, like other nitroalkanes, seems to inhibit iNOSoxy and eNOSoxy
by interacting with one or more active forms of the enzyme during catalytic turnover.

We focused on nitromethane to closely compare the effect on eNOSoxy and iNOSoxy in
terms of NO synthesis activities. The absolute activities of eNOSoxy and iNOSoxy are
significantly different. We therefore normalized the activities at various nitromethane
concentrations to the enzyme activity found in the absence of nitromethane. Figure 3.3
shows that the normalized activity for both iNOSoxy and eNOSoxy decreases as the
concentration of nitromethane increases. However, eNOSoxy shows a greater relative
shutdown of activity compared to iNOSoxy as nitromethane concentration increases.
The figure shows that nitromethane causes a larger degree of inhibition of enzyme
activity of eNOSoxy as compared to iNOSoxy.
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Figure 3.3 Comparison of the normalized enzyme activity of iNOSoxy (black soild
squares) with eNOSoxy (black solid circles) in the presence of nitromethane. Data are
average of three trials. Bars represent standard deviations
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CORRELATION OF NOSoxy-MEDIATED CATALYTIC REDUCTION OF
NITROALKANES AND OBSERVED of NINHIBITION OF NOS REACTION
Our results show that iNOSoxy and eNOSoxy mediate the electrocatalytic
reduction of simple nitroalkanes used in this investigation; namely, nitromethane,
nitroethane, and nitropropane. We compared and contrasted electrocatalytic responses of
iNOSoxy- and eNOSoxy-modified electrodes in the presence of the various nitroalkanes
using the cyclic voltammetry. Both enzyme isoforms (iNOSoxy and eNOSoxy) exhibit
typical saturation kinetics as the concentration of substrates is increased. We found that
the Km values of iNOSoxy are higher than those of eNOSoxy, indicating a higher
binding affinity of the nitroalkanes to the active form of eNOSoxy as compared to
iNOSoxy during catalytic reduction.
On a related front, we examined if the binding interaction of nitroalkanes with
active forms of eNOSoxy and iNOSoxy as implied from the electrocatalytic reductions
of nitroalkanes on NOSoxy-modified electrodes correlate with the NOS reaction
inhibition in the presence of the same nitroalkanes. We found that nitric oxide synthesis
as catalyzed by iNOSoxy and eNOSoxy is significantly affected in the presence of
nitrolkanes. The degree of inhibition is higher as the concentration of nitroalkane
increases. Interestingly, we found that nitromethane catalytic reduction by eNOSoxy
shows a lower Km value compared to the iNOSoxy case. In parallel, we show that the
inhibitory effect of nitromethane on the NOS reaction by eNOSoxy is more drastic than
its effect on the NOS reaction by iNOSoxy. While the underlying reason for this
differential effect on iNOSoxy and eNOSoxy is not clearly known at this time, the
correlation of Km values of the NOSoxy-mediated catalytic reduction of nitromethane
and its inhibitory effect on the NOS reaction may find an explanation in structural
differences of eNOSoxy and iNOSoxy. The distinct effects of nitromethane on catalytic
activities of eNOSoxy and iNOSoxy may be attributed to the environment around the
heme group in the two isoforms; however, early structural studies established that the
heme active site is highly conserved in iNOSoxy and eNOSoxy [58]. In general, NOS
isozymes show a 60 to 70 % homology. Despite the near identical active site structure of
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NOS isoforms, a number of structure-based NOS inhibitors have been reported, which
capitalize on distinct features at or near the active site. This features include amino acid
changes, differential effects of induced conformational changes, or distinct changes in
steric crowding, to cite a few [59] [60] [61] [62]. The simple nitroalkanes used in this
work, including nitromethane, are small organic molecules and are not expected to
benefit from the interactions reported for bulkier NOS inhibitors. However, distinct
features such as the access gate to the active site of iNOSoxy versus eNOSoxy, or the
nature of select amino acids lining their access channel, may affect the extent of access
of nitromethane and its exposure to the heme active site from the solution bulk. In terms
of differential access, previous reports have invoked the narrower substrate access
channel in iNOS as compared to eNOS as one factor among many that rationalize the
poor inhibitory potency of select nitroarginine-based dipeptides[59]. The active site of
eNOS itself is larger than that of iNOS [63]. While the situation may be different in the
case of the small nitroalkanes used here, the relatively wider access channel to the heme
active site in eNOSoxy as compared to iNOSoxy is expected to result in a higher
exposure of the heme catalytic site to the small nitroalkane molecules, which would
translate to a relative higher degree of inhibition of the catalytic activity of eNOSoxy
versus iNOSoxy. Also, the nitro group of nitromethane and other nitroalkanes used in
this work is expected to dynamically interact with residues in the access channel and at
the active site. This electron-withdrawing group on bulkier inhibitors is known to
hydrogen bond to nearby amide nitrogens as well as to side chain heteroatoms. The
relatively narrow channel and small active site of iNOS versus eNOS, in concert with
few non-conserved residues (e.g. Phe 475 in eNOS versus Tyr 486 in iNOS; Ser 356 in
eNOS versus Asn 367 in iNOS; Ala 448 in eNOS versus Ile 459 in iNOS) and their
expected distinct dynamic electrostatic interaction with the nitro group of nitromethane
may also explain the larger effect on eNOS catalysis. The same structural considerations
may explain the correlated Km values observed by cyclic voltammetry for eNOSoxyand iNOS-oxy mediated catalytic reduction of nitroalkanes on NOSoxy-modified
pyrolytic graphite electrodes.
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